CDRH Y2K Website Needs Better Publicity Prior To Third-Party Audits - GAO
This article was originally published in The Gray Sheet
Executive Summary
FDA needs a coordinated publicity campaign to familiarize manufacturers and hospitals with its Biomedical Equipment Clearinghouse website addressing year 2000 compliance prior to phasing in validation/verification audits of high-risk device firms on June 1, according to the General Accounting Office.
You may also be interested in...
GAO Optimistic About FDA Y2K Readiness Measures For High-Risk Devices
The General Accounting Office has a higher level of confidence in year 2000 readiness of high-risk medical devices than it did roughly five months ago, GAO Civil Agencies Information Systems Accounting and Information Management Division Director Joel Willemssen said.
Dr Reddy’s Knocked Back On Rituximab In US
Dr Reddy’s has received a complete response letter from the US FDA, knocking back its proposed rituximab biosimilar rival to Rituxan.